Centre for Big Data Research in Health, UNSW Sydney, Sydney, Australia.
National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia.
PLoS One. 2020 Mar 19;15(3):e0230373. doi: 10.1371/journal.pone.0230373. eCollection 2020.
Cancer of unknown primary (CUP) is a late-stage malignancy with poor prognosis, but we know little about what diagnostic tests and procedures people with CUP receive prior to diagnosis. The purpose of this study was to determine how health service utilisation prior to diagnosis for people with cancer-registry notified CUP differs from those notified with metastatic cancer of known primary.
We identified people with a cancer registry notification of CUP (n = 327) from the 45 and Up Study, a prospective cohort of 266,724 people ≥45 years in New South Wales, Australia, matched with up to three controls with a diagnosis of metastatic cancer of known primary (n = 977). Baseline questionnaire data were linked to population health data to identify all health service use, diagnostic tests, and procedures in the month of diagnosis and 3 months prior. We used conditional logistic regression to estimate adjusted odds ratios (ORs) and 95% confidence intervals (CIs).
After adjusting for age and educational attainment, people with a cancer-registry notified CUP diagnosis were more likely to be an aged care resident (OR = 2.78, 95%CI 1.37-5.63), have an emergency department visit (OR = 1.65, 95%CI 1.23-2.21), serum tumor marker tests (OR = 1.51, 95%CI 1.12-2.04), or a cytology test without immunohistochemistry (OR = 2.01, 95%CI 1.47-2.76), and less likely to have a histopathology test without immunohistochemistry (OR = 0.43, 95%CI 0.31-0.59). Neither general practitioner, specialist, allied health practitioner or nurse consultations, hospitalisations, nor imaging procedures were associated with a CUP diagnosis.
The health service and diagnostic pathway to diagnosis differs markedly for people notified with CUP compared to those with metastatic cancer of known primary. While these differences may indicate missed opportunities for earlier detection and appropriate management, for some patients they may be clinically appropriate.
癌症原发灶不明(CUP)是一种预后较差的晚期恶性肿瘤,但我们对 CUP 患者在诊断前接受的诊断测试和程序知之甚少。本研究的目的是确定在诊断前,癌症登记处通知 CUP 患者(n = 327)与通知转移性癌症原发病灶的患者(n = 977)相比,他们的医疗服务利用情况有何不同。
我们从澳大利亚新南威尔士州的 45 岁及以上研究中确定了癌症登记处通知 CUP 的患者(n = 327),这是一项前瞻性队列研究,包括 266724 名 45 岁及以上的人群,与通知转移性癌症原发病灶的 3 名患者(n = 977)相匹配。基线问卷数据与人群健康数据相关联,以确定诊断当月和前 3 个月的所有医疗服务使用、诊断测试和程序。我们使用条件逻辑回归估计调整后的优势比(OR)和 95%置信区间(CI)。
在调整年龄和教育程度后,癌症登记处通知 CUP 诊断的患者更有可能成为老年护理居民(OR = 2.78,95%CI 1.37-5.63)、急诊就诊(OR = 1.65,95%CI 1.23-2.21)、血清肿瘤标志物测试(OR = 1.51,95%CI 1.12-2.04)或未经免疫组织化学检测的细胞学检查(OR = 2.01,95%CI 1.47-2.76),而未经免疫组织化学检测的组织病理学检查则较少(OR = 0.43,95%CI 0.31-0.59)。全科医生、专家、辅助健康从业者或护士的咨询、住院或影像学检查与 CUP 诊断均无关联。
与转移性癌症原发病灶相比,癌症登记处通知 CUP 的患者的医疗服务和诊断途径明显不同。虽然这些差异可能表明错过了早期检测和适当治疗的机会,但对一些患者来说,它们可能是临床合理的。